OTC

Strength

5; 50; 2.5 mg/5mL; mg/5mL; mg/5mL

NDC

00031871612

Classification

Brand

Dosage Form

LIQUID

Route

ORAL

Last Updated

5/20/2015

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M001

On Market Since

9/1/2009

Pharmacological Classes

Adrenergic alpha1-Agonists
Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+4.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.